Skip to main content
logo
GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
71.77
+1.46 (2.08%)
At close: Aug 7, 2026, 4:00 PM EDT
71.90
+0.13 (0.18%)
Pre-market: Aug 10, 2026, 5:50 AM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Product Revenue
14.04B13.66B13.08B
Service Revenue
7.23B6.96B6.60B
Revenue (Total)
21.27B20.63B19.67B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Radiology Revenue
9.59B9.25B8.86B
Advanced Visualization Solutions (AVS) Revenue
5.55B5.35B5.13B
Total Advanced Imaging Solutions (AIS) Revenue
15.14B14.60B13.99B
Pharmaceutical Diagnostics (PDx) Revenue
3.15B2.90B2.51B
Patient Care Solutions (PCS) Revenue
2.94B3.09B3.13B
Other Revenue
46.00M40.00M52.00M
Revenue (Total)
21.27B20.63B19.67B

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Pharmaceutical Diagnostics (PDx) Revenue
3.15B2.90B2.51B
Patient Care Solutions (PCS) Revenue
2.94B3.09B3.13B
Other Revenue
46.00M40.00M52.00M
Revenue (Total)
21.27B20.63B19.67B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
USCAN Revenue
9.79B9.53B8.98B
EMEA Revenue
5.67B5.43B5.05B
China Revenue
2.24B2.25B2.36B
Rest of World Revenue
3.56B3.42B3.28B
Revenue (Other)
1.00M--
Revenue (Total)
21.27B20.63B19.67B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Imaging EBIT (Post-Q2 2024)
-891.00M962.00M
Advanced Visualization Solutions (AVS) EBIT
-1.18B1.12B
Advanced Imaging Solutions (AIS) Segment EBIT
2.16B2.07B2.08B
Patient Care Solutions (PCS) Segment EBIT
85.00M209.00M347.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT
901.00M872.00M783.00M
Other Segment EBIT
10.00M7.00M2.00M
Operating Income (Other)
-417.00M-2.46B-2.67B
Operating Income (Total)
2.73B2.76B2.63B

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Patient Care Solutions (PCS) Segment EBIT
85.00M209.00M347.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT
901.00M872.00M783.00M
Other Segment EBIT
10.00M7.00M2.00M
Operating Income (Total)
2.73B2.76B2.63B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Products Remaining Performance Obligations (RPO)
5.18B5.00B4.76B
Services Remaining Performance Obligations (RPO)
10.94B10.73B9.74B
Total Remaining Performance Obligations (RPO)
16.12B15.73B14.49B